Cargando…
Nanoplatforms for magnetic resonance imaging of cancer
The application of biomedical nanotechnology in magnetic resonance imaging (MRI) is expect to have a major impact leading to the development of new contrast drug candidates on the nanoscale (1–100 nm) that are able to react with specific biological targets at a molecular level. One of the major chal...
Autores principales: | Cywińska, Monika A., Grudziński, Ireneusz P., Cieszanowski, Andrzej, Bystrzejewski, Michał, Popławska, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389923/ https://www.ncbi.nlm.nih.gov/pubmed/22802828 |
Ejemplares similares
-
Cytotoxicity evaluation of carbon-encapsulated iron nanoparticles in melanoma cells and dermal fibroblasts
por: Grudzinski, Ireneusz P., et al.
Publicado: (2013) -
Non-Contrast-Enhanced Whole-Body Magnetic Resonance Imaging in the General Population: The Incidence of Abnormal Findings in Patients 50 Years Old and Younger Compared to Older Subjects
por: Cieszanowski, Andrzej, et al.
Publicado: (2014) -
Nanocomposites as biomolecules delivery agents in nanomedicine
por: Bamburowicz-Klimkowska, Magdalena, et al.
Publicado: (2019) -
New Clathrin-Based Nanoplatforms for Magnetic Resonance Imaging
por: Vitaliano, Gordana D., et al.
Publicado: (2012) -
Recent development of pH‐responsive theranostic nanoplatforms for magnetic resonance imaging‐guided cancer therapy
por: Li, Xu, et al.
Publicado: (2023)